✦ LIBER ✦

Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease

✍ Scribed by Cho, J.-Y.; Paik, Y.-H.; Sohn, W.; Cho, H. C.; Gwak, G.-Y.; Choi, M. S.; Lee, J. H.; Koh, K. C.; Paik, S. W.; Yoo, B. C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P549 CHRONIC HEPATITIS B PATIENTS TREATE

✍ Cho, J.-Y.; Paik, Y.-H.; Sohn, W.; Cho, H.C.; Gwak, G.-Y.; Choi, M.S.; Lee, J.H. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Determinants of early mortality in patie

✍ Robert J. Fontana; Hie-Won L. Hann; Robert P. Perrillo; John M. Vierling; Theres 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Should we routinely treat patients with

✍ Dimitrios Vassilopoulos 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Should we routinely treat patients with

✍ Massimo Marignani; Marco Canzoni; Raffaele D'Amelio; Emanuela De Santis; Alessan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 202 KB

768 LOW RISK OF HEPATITIS B REACTIVATION

✍ A. Aghemo; M. Vigano; M. Iavarone; M.G. Rumi; F. Agnelli; P. Lampertico; M.F. Do 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

P1049 RISK FACTORS FOR HEPATOCELLULAR CA

✍ Yamada, R.; Hiramatsu, N.; Morishita, N.; Harada, N.; Oze, T.; Yakushijin, T.; M 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB